Khalid Mumtaz MD MSc (clinical epidemiology)
Hepatology & Liver Transplantation
Associate Professor
Join to View Full Profile
410 W 10th AveColumbus, OH 43210
Phone+1 614-293-6255
Fax+1 614-293-8518
Dr. Mumtaz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Dow University of Health SciencesClass of 1993
Certifications & Licensure
OH State Medical License 2014 - 2023
Publications & Presentations
PubMed
- 6 citationsImpact of GLP-1RA on the Risk of Adverse Liver Outcomes Among Patients With Alcohol-Associated Liver Disease and Type 2 Diabetes.Zayed Rashid, Selamawit Woldesenbet, Mujtaba Khalil, Sidharth Iyer, Muhammad Muntazir Mehdi Khan
Liver International. 2025-04-01 - Impact of Preoperative Glucagon-Like Peptide-1 Receptor Agonist on Outcomes Following Major Surgery.Zayed Rashid, Selamawit Woldesenbet, Mujtaba Khalil, Abdullah Altaf, Jun Kawashima
World Journal of Surgery. 2025-03-01 - 1 citationsUtility of Advanced Age as a Predictor of Outcomes in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt.Gavisha Waidyaratne, Sajid Jalil, Alex Liu, Sandya Liyanarachchi, Mina S Makary
Digestive Diseases and Sciences. 2025-03-01
Press Mentions
Pandemic Drinking Triggers Surge in Liver TransplantsAugust 5th, 2021- Mallinckrodt Presents Data on TERLIVAZ® (Terlipressin) for Injection in Patients with Hepatorenal Syndrome (HRS) at the 2024 Digestive Disease Week® (DDW)May 22nd, 2024
- Mallinckrodt Presents Data on TERLIVAZ® (Terlipressin) for Injection in Patients with Hepatorenal Syndrome (HRS) at the 2024 Digestive Disease Week® (DDW)May 22nd, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
